399 related articles for article (PubMed ID: 18645041)
1. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
Loos T; Mortier A; Gouwy M; Ronsse I; Put W; Lenaerts JP; Van Damme J; Proost P
Blood; 2008 Oct; 112(7):2648-56. PubMed ID: 18645041
[TBL] [Abstract][Full Text] [Related]
2. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
[TBL] [Abstract][Full Text] [Related]
3. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.
Struyf S; Noppen S; Loos T; Mortier A; Gouwy M; Verbeke H; Huskens D; Luangsay S; Parmentier M; Geboes K; Schols D; Van Damme J; Proost P
J Immunol; 2009 Jan; 182(1):666-74. PubMed ID: 19109200
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding.
Cox JH; Dean RA; Roberts CR; Overall CM
J Biol Chem; 2008 Jul; 283(28):19389-99. PubMed ID: 18411283
[TBL] [Abstract][Full Text] [Related]
5. Citrullination of TNF-α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines.
Moelants EA; Mortier A; Grauwen K; Ronsse I; Van Damme J; Proost P
Cytokine; 2013 Jan; 61(1):161-7. PubMed ID: 23075670
[TBL] [Abstract][Full Text] [Related]
6. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.
Metzemaekers M; Mortier A; Janssens R; Boff D; Vanbrabant L; Lamoen N; Van Damme J; Teixeira MM; De Meester I; Amaral FA; Proost P
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703769
[TBL] [Abstract][Full Text] [Related]
8. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
10. Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity.
Hensbergen PJ; van der Raaij-Helmer EM; Dijkman R; van der Schors RC; Werner-Felmayer G; Boorsma DM; Scheper RJ; Willemze R; Tensen CP
Eur J Biochem; 2001 Sep; 268(18):4992-9. PubMed ID: 11559369
[TBL] [Abstract][Full Text] [Related]
11. Peptidylarginine deiminase 2 suppresses inhibitory {kappa}B kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Lee HJ; Joo M; Abdolrasulnia R; Young DG; Choi I; Ware LB; Blackwell TS; Christman BW
J Biol Chem; 2010 Dec; 285(51):39655-62. PubMed ID: 20937835
[TBL] [Abstract][Full Text] [Related]
12. Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis.
Moelants EA; Loozen G; Mortier A; Martens E; Opdenakker G; Mizgalska D; Szmigielski B; Potempa J; Van Damme J; Teughels W; Proost P
Infect Immun; 2014 Jun; 82(6):2511-9. PubMed ID: 24686061
[TBL] [Abstract][Full Text] [Related]
13. Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration.
Jang B; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
Prion; 2013; 7(1):42-6. PubMed ID: 23022892
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational modification of the NH2-terminal region of CXCL5 by proteases or peptidylarginine Deiminases (PAD) differently affects its biological activity.
Mortier A; Loos T; Gouwy M; Ronsse I; Van Damme J; Proost P
J Biol Chem; 2010 Sep; 285(39):29750-9. PubMed ID: 20630876
[TBL] [Abstract][Full Text] [Related]
15. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
[TBL] [Abstract][Full Text] [Related]
16. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.
Proost P; Loos T; Mortier A; Schutyser E; Gouwy M; Noppen S; Dillen C; Ronsse I; Conings R; Struyf S; Opdenakker G; Maudgal PC; Van Damme J
J Exp Med; 2008 Sep; 205(9):2085-97. PubMed ID: 18710930
[TBL] [Abstract][Full Text] [Related]
17. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
Colvin RA; Campanella GS; Manice LA; Luster AD
Mol Cell Biol; 2006 Aug; 26(15):5838-49. PubMed ID: 16847335
[TBL] [Abstract][Full Text] [Related]
18. Protein Citrullination by Peptidyl Arginine Deiminase/Arginine Deiminase Homologs in Members of the Human Microbiota and Its Recognition by Anti-Citrullinated Protein Antibodies.
Pérez-Pérez ME; Nieto-Torres E; Bollain-Y-Goytia JJ; Delgadillo-Ruíz L
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791230
[TBL] [Abstract][Full Text] [Related]
19. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.
Colvin RA; Campanella GS; Sun J; Luster AD
J Biol Chem; 2004 Jul; 279(29):30219-27. PubMed ID: 15150261
[TBL] [Abstract][Full Text] [Related]
20. Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.
Yang ML; Sodré FMC; Mamula MJ; Overbergh L
Front Immunol; 2021; 12():678953. PubMed ID: 34140951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
